Mitotan
98%
- Product Code: 126569
Alias:
2,4'-Dididi; Chlorobenzenedichloroethane, Mitotane
CAS:
53-19-0
Molecular Weight: | 320.04 g./mol | Molecular Formula: | C₁₄H₁₀Cl₄ |
---|---|---|---|
EC Number: | 200-166-6 | MDL Number: | MFCD00000850 |
Melting Point: | 77-78 °C(lit.) | Boiling Point: | |
Density: | Storage Condition: | 2~8°C |
Product Description:
Mitotan is primarily used in the treatment of adrenocortical carcinoma, a rare cancer affecting the adrenal cortex. It works by inhibiting the production of hormones in the adrenal glands and directly damaging adrenal cells, helping to control the symptoms and progression of the disease. Additionally, it is sometimes employed in managing Cushing's syndrome, particularly when caused by adrenal tumors, by reducing excessive cortisol levels. Mitotan is often administered when surgery is not an option or as an adjunct therapy post-surgery to prevent recurrence. Its use requires careful monitoring due to potential side effects and the need for dosage adjustments based on individual response.
Product Specification:
Test | Specification |
---|---|
Purity (%) | 97.5-100 |
Melting Point | 75 Degree Celsius-81 Degree Celsius |
Appearance | Colorless Crystals Or White Crystalline Powder |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | $42.00 |
+
-
|
5.000 | 10-20 days | $134.41 |
+
-
|
25.000 | 10-20 days | $460.85 |
+
-
|
Mitotan
Mitotan is primarily used in the treatment of adrenocortical carcinoma, a rare cancer affecting the adrenal cortex. It works by inhibiting the production of hormones in the adrenal glands and directly damaging adrenal cells, helping to control the symptoms and progression of the disease. Additionally, it is sometimes employed in managing Cushing's syndrome, particularly when caused by adrenal tumors, by reducing excessive cortisol levels. Mitotan is often administered when surgery is not an option or as an adjunct therapy post-surgery to prevent recurrence. Its use requires careful monitoring due to potential side effects and the need for dosage adjustments based on individual response.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :